180 related articles for article (PubMed ID: 29508538)
1. Does the tumour microenvironment alter tumorigenesis and clinical response in transmissible venereal tumour in dogs?
Ballestero Fêo H; Montoya Flórez L; Yamatogi RS; Prado Duzanski A; Araújo JP; Oliveira RA; Rocha NS
Vet Comp Oncol; 2018 Sep; 16(3):370-378. PubMed ID: 29508538
[TBL] [Abstract][Full Text] [Related]
2. Canine transmissible venereal tumour: a morphological and immunohistochemical study of 11 tumours in growth phase and during regression after chemotherapy.
Gonzalez CM; Griffey SM; Naydan DK; Flores E; Cepeda R; Cattaneo G; Madewell BR
J Comp Pathol; 2000 May; 122(4):241-8. PubMed ID: 10805977
[TBL] [Abstract][Full Text] [Related]
3. Combination therapy using intratumoral bacillus Calmette-Guerin (BCG) and vincristine in dogs with transmissible venereal tumours: therapeutic efficacy and histological changes.
Mukaratirwa S; Chitanga S; Chimatira T; Makuleke C; Sayi ST; Bhebhe E
J S Afr Vet Assoc; 2009 Jun; 80(2):92-6. PubMed ID: 19831270
[TBL] [Abstract][Full Text] [Related]
4. Canine transmissible venereal tumour: a review.
Ganguly B; Das U; Das AK
Vet Comp Oncol; 2016 Mar; 14(1):1-12. PubMed ID: 23981098
[TBL] [Abstract][Full Text] [Related]
5. Intratumoral recombinant human interferon alpha-2a and vincristine combination therapy in canine transmissible venereal tumour.
Kanca H; Tez G; Bal K; Ozen D; Alcigir E; Atalay Vural S
Vet Med Sci; 2018 Nov; 4(4):364-372. PubMed ID: 30117719
[TBL] [Abstract][Full Text] [Related]
6. Canine transmissible venereal tumor: First report of three clinical cases from Tripoli, Libya.
Hiblu MA; Khabuli NM; Gaja AO
Open Vet J; 2019 Jul; 9(2):103-105. PubMed ID: 31360646
[TBL] [Abstract][Full Text] [Related]
7. Cell-mediated immunity and expression of MHC class I and class II molecules in dogs naturally infected by canine transmissible venereal tumor: Is there complete spontaneous regression outside the experimental CTVT?
do Prado Duzanski A; Flórez LMM; Fêo HB; Romagnoli GG; Kaneno R; Rocha NS
Res Vet Sci; 2022 Jul; 145():193-204. PubMed ID: 35240476
[TBL] [Abstract][Full Text] [Related]
8. Interactions of host IL-6 and IFN-gamma and cancer-derived TGF-beta1 on MHC molecule expression during tumor spontaneous regression.
Hsiao YW; Liao KW; Chung TF; Liu CH; Hsu CD; Chu RM
Cancer Immunol Immunother; 2008 Jul; 57(7):1091-104. PubMed ID: 18259750
[TBL] [Abstract][Full Text] [Related]
9. Vincristine and ivermectin combination chemotherapy in dogs with natural transmissible venereal tumor of different cyto-morphological patterns: A prospective outcome evaluation.
Ferreira Bulhosa L; Estrela-Lima A; da Silva Solcà M; Diniz Gonçalves GS; Larangeira DF; de Pinho FA; Barrouin-Melo SM
Anim Reprod Sci; 2020 May; 216():106358. PubMed ID: 32414469
[TBL] [Abstract][Full Text] [Related]
10. Transmissible venereal tumor: a retrospective study of 29 cases.
Rogers KS; Walker MA; Dillon HB
J Am Anim Hosp Assoc; 1998; 34(6):463-70. PubMed ID: 9826280
[TBL] [Abstract][Full Text] [Related]
11. Predictive factors for the regression of canine transmissible venereal tumor during vincristine therapy.
Scarpelli KC; Valladão ML; Metze K
Vet J; 2010 Mar; 183(3):362-3. PubMed ID: 19109042
[TBL] [Abstract][Full Text] [Related]
12. Computerized Cytomorphometric and Cytomorphological Analysis of Canine Transmissible Venereal Tumours.
Setthawongsin C; Tangkawattana S; Rungsipipat A; Techangamsuwan S
J Comp Pathol; 2018 Aug; 163():18-22. PubMed ID: 30213369
[TBL] [Abstract][Full Text] [Related]
13. Primary intranasal transmissible venereal tumour in the dog: a retrospective study of six spontaneous cases.
Papazoglou LG; Koutinas AF; Plevraki AG; Tontis D
J Vet Med A Physiol Pathol Clin Med; 2001 Sep; 48(7):391-400. PubMed ID: 11599677
[TBL] [Abstract][Full Text] [Related]
14. Cell cycle kinetics, apoptosis rates and gene expressions of MDR-1, TP53, BCL-2 and BAX in transmissible venereal tumour cells and their association with therapy response.
Flórez MM; Fêo HB; da Silva GN; Yamatogi RS; Aguiar AJ; Araújo JP; Rocha NS
Vet Comp Oncol; 2017 Sep; 15(3):793-807. PubMed ID: 26879698
[TBL] [Abstract][Full Text] [Related]
15. A Clinico-pathological study on the effect of vincristine on transmissible venereal tumour in dogs.
Nak D; Nak Y; Cangul IT; Tuna B
J Vet Med A Physiol Pathol Clin Med; 2005 Sep; 52(7):366-70. PubMed ID: 16109105
[TBL] [Abstract][Full Text] [Related]
16. The role of the multi-drug resistance 1, p53, b cell lymphoma 2, and bcl 2-associated X genes in the biologic behavior and chemotherapeutic resistance of canine transmissible venereal tumors.
Alzate JM; Montoya-Florez LM; Pérez JE; Rocha NS; Pedraza-Ordonez FJ
Vet Clin Pathol; 2019 Dec; 48(4):730-739. PubMed ID: 31777108
[TBL] [Abstract][Full Text] [Related]
17. Effects of immunotherapy of IL-6 and IL-15 plasmids on transmissible venereal tumor in beagles.
Chou PC; Chuang TF; Jan TR; Gion HC; Huang YC; Lei HJ; Chen WY; Chu RM
Vet Immunol Immunopathol; 2009 Jul; 130(1-2):25-34. PubMed ID: 19200609
[TBL] [Abstract][Full Text] [Related]
18. The changing global distribution and prevalence of canine transmissible venereal tumour.
Strakova A; Murchison EP
BMC Vet Res; 2014 Sep; 10():168. PubMed ID: 25186078
[TBL] [Abstract][Full Text] [Related]
19. Primary transmissible venereal tumour in the nasal cavity of a dog.
Ginel PJ; Molleda JM; Novales M; Martín E; Margarito JM; López R
Vet Rec; 1995 Mar; 136(9):222-3. PubMed ID: 7771073
[No Abstract] [Full Text] [Related]
20. Transmission of canine transmissible venereal tumour between two dogs in the UK.
Hayes AM; Schiavo L; Constantino-Casas F; Desmas I; Dobson J; Draper A; Elliot J; Genain MA; Wang J; Murchison EP
J Small Anim Pract; 2023 Sep; 64(9):590-594. PubMed ID: 36990106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
